PLoS Computational BiologyCancer BiologyPeer-reviewed journal article
Inheritable cell-states shape drug-persister correlations and population dynamics in cancer cells
Anton Iyer, Adrian Alva, Adrián E. GranadaiD, Shaon ChakrabartiiD
Abstract
Drug tolerant persisters (DTPs) drive cancer therapy resistance by temporarily evading drug action, allowing multiple routes to eventual permanent resistance. Despite clear evidence for DTPs, the timing of their emergence, proliferative nature, and how their population dynamics arise from measured single-cell kinetics remain poorly understood. Here we use time-lapse microscopy data from two cancer cell lines, integrating single-cell and population measurements, to develop a quantitative description of drug persistence. Contrary to the expectation that increasing levels of genotoxic stress should lead to slower times to division and faster times to death, we observe minor changes in the single-cell intermitotic and death time distributions upon increasing cisplatin concentration. Yet, population decay rates increase 3-fold, suggesting a surprising independence of the overall dynamics from the measured birth and death rates. To explain this phenomenon, we argue that the observed lineage correlations and concentration-dependent decay rates imply cell-state dependent fate choices made both pre and post-cisplatin as opposed to just post-drug birth/death rate-based competitive fate choices. We demonstrate that these cell-states, present in the ancestors of DTP and sensitive cells, exhibit no difference in cycling speed and are inherited across 2-3 cellular generations. A stochastic model implementing these rules simultaneously recapitulates the observed decay rates and cell-fate correlations, also explaining how pre-drug fate decisions are consistent with barcoding experiments where barcode diversity remains unchanged after drug administration. Our results provide a powerful perspective on drug tolerance based on general arguments, without requiring knowledge of the underlying molecular architecture of the heterogeneous cell states.
- organism: human
- assay: imaging
- research focus: cell type annotation
- research focus: clustering
- research focus: trajectory inference
- approach: microscopy & imaging analysis
- Citations
- 5
- FWCI
- 3.16
- Field percentile
- top 8%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterogeneous, Population-Level Drug-Tolerant Persisters Exhibit Ion-Channel Remodeling and Ferroptosis Susceptibility
Corey E. Hayford, Blake Baleami, … Leonard A. Harris·bioRxiv·Feb 3, 2022
- Drug tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms
Maria Davern, Cole J. Turner, … Anthony G. Letai·Cell Death and DifferentiationPeer-reviewed·Dec 26, 2025
- Chemotherapy-induced multicellularity drives drug-tolerant persistence state in tumor cells
Jing Li, Z G Zhu, … Chunfang Liu·bioRxiv·Jul 10, 2026
- Modeling a Continuum of Drug-induced Persistence during Targeted Cancer Therapy
Ji Tae Park, Herbert Levine·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 27, 2026
- A model for the intrinsic limit of cancer therapy: duality of treatment-induced cell death and treatment-induced stemness
E. Angelini, Y. Wang, … S. Huang·bioRxiv·Oct 5, 2021
- Persister cells and their effects on cancer stabilization therapy
Mohammadreza Satouri, Philipp M. Altrock, … Kateřina Staňková·bioRxiv·Oct 16, 2026